Variables | Smoking | Alcohol consumption | Hypertension | Overweight | Obesity | Waist Circumference |
---|---|---|---|---|---|---|
Age | ||||||
 18–34 years | Reference (1) | Reference (1) | Reference (1) | Reference (1) | Reference (1) | Reference (1) |
  ≥ 35 years | 1.5 (0.5–4.8) a | 0.3 (0.2–0.6)** | 1.6 (1.3–2.1)*** | 1.5 (0.8–3.1) a | 0.7 (0.4–1.4) a | 0.97 (0.53–1.78) a |
Gender | ||||||
 Female | Reference (1) | Reference (1) | Reference (1) | Reference (1) | Reference (1) | Reference (1) |
 Male | 18.9 (0.5–47.4)*** | 3.6 (2.1–6.3)*** | 1.5 (0.9–2.4) a | 0.9 (0.5–1.9) a | 0.09 (0.03–0.3)*** | 0.3 (0.3–0.5)*** |
Educational status | ||||||
 High | Reference (1) | Reference (1) | Reference (1) | Reference (1) | Reference (1) | Reference (1) |
 Low | 0.9 (0.6–1.5) a | 0.7 (0.5–1.1) a | 0.8 (0.6–1.1) a | 1.6 (1.2–2.3)** | 1.0 (0.6–1.9) a | 1.1 (0.8–1.6) a |
Marital status | ||||||
 Married | Reference (1) | Reference (1) | Reference (1) | Reference (1) | Reference (1) | Reference (1) |
 Single | 3.6 (1.3–9.9)* | 0.9 (0.4–1.9) a | 1.7 (0.9–3.0) a | 0.8 (0.4–1.7) a | 0.7 (0.3–1.5) a | 0.8 (0.4–1.6) a |
 Cohabiting | 3.9 (1.3–11.9)* | 0.9 (0.4–2.1) a | 1.1 (0.5–2.4) a | 0.3 (0.1–1.0)* | 0.7 (0.2–1.9) a | 0.7 (0.3–1.9) a |
 Divorced | 5.6 (1.4–22.2)* | 0.7 (0.2–3.1) a | 2.2 (0.7–6.0) a | 0.2 (0.02–1.2) a | 3.1 (0.9–10.4) a | 1.6 (0.5–5.1) a |
 Separated | 2.2 (0.4–11.6) a | 0.2 (0.02–1.4) a | 2.2 (0.8–5.9) a | 0.8 (0.2–2.6) a | 0.6 (0.2–2.6) a | 1.1 (0.4–3.7) a |
 Widowed | 1.2 (0.2–6.3) a | 0.4 (0.1–1.6) a | 2.7 (1.2–6.0)* | 1.0 (0.4–2.6) a | 1.0 (0.3–2.9) a | 1.6 (0.6–4.1) a |
Work status | ||||||
 Working | Reference (1) | Reference (1) | Reference (1) | Reference (1) | Reference (1) | Reference (1) |
 Not working | 0.8 (0.5–1.1)a | 2.8 (0.7–10.8) a | 0.9 (0.7–1.1)a | 0.08 (0.02–0.3)a | 1.2 (0.3–5.1) a | 0.8 (2.1–2.9) a |
ART Regimen | ||||||
 FDC | Reference (1) | Reference (1) | Reference (1) | Reference (1) | Reference (1) | Reference (1) |
 Dumiva and efavirenz | 0.9 (0.3–2.2)a | 0.3 (0.1–0.7)* | 2.1 (1.1–3.8)* | 0.8 (0.4–1.7)a | 1.7 (0.8–3.3)a | 2.1 (1.2–3.8)* |
 Dumiva and alluvia | 0.6 (0.1–2.7)a | 0.7 (0.2–1.9)a | 3.3 (1.4–7.5)** | 1.4 (0.5–3.4)a | 0.8 (0.3–2.6)a | 1.2 (0.5–2.8)a |
 Efavirenz and lamividine | – | – | – | 3.7 (0.2–59.7)a | – | 2.6 (0.2–42.4)a |
 Tenamine and neverapine | 0.4 (0.05–3.2)a | 0.3 (0.1–1.5)a | 1.7 (0.7–4.5)a | 0.7 (0.2–2.5)a | 1.6 (0.6–4.8)a | 1.9 (0.7–4.9)a |
 Alluvia and tenefovir | – | 1.9 (0.3–11.7)a | – | 2.4 (0.4–15.0)a | 1.2 (0.1–10.6)a | 1.7 (0.3–10.6)a |
Duration of ART | ||||||
  ≥ 5 years | Reference (1) | Reference (1) | Reference (1) | Reference (1) | Reference (1) | Reference (1) |
 3–4 years | 0.8 (0.3–2.5)a | 0.6 (0.2–1.6)a | 1.6 (0.7–3.5)a | 0.7 (0.3–1.5)a | 1.6 (0.8–3.2)a | 0.8 (0.2–4.2)a |
  ≤ 2 years | 1.2 (0.5–2.9)a | 1.4 (0.7–3.0)a | 0.6 (0.3–1.3)a | 1.7 (0.9–3.0)a | 0.9 (0.4–1.7)a | 0.3 (0.04–2.5)a |